Common biological networks underlie genetic risk for alcoholism in African- and European-American populations.
- Authors
- Kos, M Z; Yan, J; Dick, D M; Agrawal, A; Bucholz, K K; Rice, J P; Johnson, E O; Schuckit, M; Kuperman, S; Kramer, J; Goate, A M; Tischfield, J A; Foroud, T; Nurnberger, J; Hesselbrock, V; Porjesz, B; Bierut, L J; Edenberg, H J; Almasy, L
- Year
- 2013
- Journal
- Genes, brain, and behavior
- PMID
- 23607416
- DOI
- 10.1111/gbb.12043
- PMCID
- PMC3709451
Alcohol dependence (AD) is a heritable substance addiction with adverse physical and psychological consequences, representing a major health and economic burden on societies worldwide. Genes thus far implicated via linkage, candidate gene and genome-wide association studies (GWAS) account for only a small fraction of its overall risk, with effects varying across ethnic groups. Here we investigate the genetic architecture of alcoholism and report on the extent to which common, genome-wide SNPs collectively account for risk of AD in two US populations, African-Americans (AAs) and European-Americans (EAs). Analyzing GWAS data for two independent case-control sample sets, we compute polymarker scores that are significantly associated with alcoholism (P = 1.64 × 10(-3) and 2.08 × 10(-4) for EAs and AAs, respectively), reflecting the small individual effects of thousands of variants derived from patterns of allelic architecture that are population specific. Simulations show that disease models based on rare and uncommon causal variants (MAF < 0.05) best fit the observed distribution of polymarker signals. When scoring bins were annotated for gene location and examined for constituent biological networks, gene enrichment is observed for several cellular processes and functions in both EA and AA populations, transcending their underlying allelic differences. Our results reveal key insights into the complex etiology of AD, raising the possibility of an important role for rare and uncommon variants, and identify polygenic mechanisms that encompass a spectrum of disease liability, with some, such as chloride transporters and glycine metabolism genes, displaying subtle, modifying effects that are likely to escape detection in most GWAS designs.
Variance in alcohol dependence (AD) explained by genome-wide scores for African-American and European-American subjectsPolymarker scoring routines based on AD status were designed for thirteen GWAS significance thresholds (plotted against the x axis) using COGA data and applied to SAGE target samples. The y axis represents Nagelkerke’s pseudo R2, the amount of variation in AD accounted by the SAGE scores, computed for routines that are both population-matched and mismatched across the COGA and SAGE data sets.
Scoring analysis stratified by non-overlapping bins of score risk alleles based on (a) GWAS P-values and (b) minor allele frequenciesVariance explained was standardized by SNP counts for the respective bins.
Variance explained by genome-wide scoring routines for observed and simulated disease phenotypes according to MAF classThe variances explained, derived from MAF bins comprised of different score alleles, are presented for six disease models for each study population. The models represent either 100, 1,000 or 5,000 causal variants, which were randomly drawn from SNP data excluded from the original design of scoring routines, limited to either rare/uncommon markers (<5% MAF) or common markers (>5% MAF). Each model was replicated 100 times. Disease heritability was set at 0.65, with causal effect sizes fixed for all loci. Observed R2 results for AD are given as black, dotted lines.
Empirical P-values of four, top-ranking biological ontologies based on permuted (1,000X) Fisher’s exact tests of gene enrichment in European- and African-American samplesAllele bins, delineated by genome-wide association P-values at cumulative increments of 0.05, were annotated for gene location using UCSC hg18 coordinates.
| Name | Type |
|---|---|
| AA | cohort |
| AA gene list local | cohort |
| AA SAGE local | cohort |
| AbdB local | gene |
| ABDB local | gene |
| acetaldehyde | drug |
| ADH1B | gene |
| ADH4 | gene |
| AD liability local | phenotype |
| AD status | phenotype |
| African American | cohort |
| African-Americans | cohort |
| alcohol | phenotype |
| alcohol dependence | phenotype |
| alcoholism | phenotype |
| Alzheimer's disease | phenotype |
| Alzheimer's disease risk local | phenotype |
| antisocial personality disorder | phenotype |
| case-control phenotypes | phenotype |
| causal loci local | variant |
| causal variant | cohort |
| causal variants | cohort |
| childhood conduct disorder | phenotype |
| chloride transport local | gene |
| cocaine | phenotype |
| COGA sites | cohort |
| COGEND | cohort |
| Collaborative Study on the Genetics of Alcoholism (COGA) | cohort |
| common GWAS markers local | variant |
| common variants | cohort |
| controls | cohort |
| copy number variants | variant |
| Crohn’s disease | phenotype |
| disease phenotypes | phenotype |
| EA | cohort |
| EA gene list local | cohort |
| EP300 | gene |
| European ancestry | cohort |
| European-derived risk alleles local | variant |
| European population | cohort |
| Family study of cocaine dependence | cohort |
| GABA | phenotype |
| GABAA receptor | drug |
| GABRA2 | gene |
| GCTA | drug |
| glycine | drug |
| glycine and serine metabolism local | gene |
| Health Maintenance Organizations local | cohort |
| height | phenotype |
| homeotic (Hox) AbdB genes local | gene |
| HOX AbdB genes local | gene |
| Illicit substance abuse local | phenotype |
| Illicit substance dependence local | phenotype |
| intelligence | phenotype |
| MAF | gene |
| missing heritability | phenotype |
| nicotine | drug |
| NOD2 local | gene |
| Notch | gene |
| participants | cohort |
| psychiatric disorders | phenotype |
| Purcell et al. 2009 schizophrenia cohort local | cohort |
| rare risk allele local | variant |
| rare variant | cohort |
| rare variation | cohort |
| reward system | anatomy |
| risk allele | cohort |
| rs1229984 | variant |
| SAGE | cohort |
| schizophrenia | phenotype |
| serine | drug |
| simulated disease local | phenotype |
| SNP | cohort |
| Study of Addiction: Genetics and Environment | cohort |
| substance abuse | phenotype |
| uncommon risk allele local | variant |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis. | Blum K et al. | — | 2023 | → |
| Clinical Neuroscience of Addiction: What Clinical Psychologists Need to Know and Why. | Ray LA et al. | — | 2021 | → |
| Exploring how Family and Neighborhood Stressors Influence Genetic Risk for Adolescent Conduct Problems and Alcohol Use. | Bares CB et al. | — | 2020 | → |
| On the path towards personalized medicine: Implications of pharmacogenetic studies of alcohol use disorder medications. | Nieto SJ et al. | — | 2020 | → |
| Beyond genome-wide significance: integrative approaches to the interpretation and extension of GWAS findings for alcohol use disorder. | Salvatore JE et al. | — | 2019 | → |
| Shared additive genetic variation for alcohol dependence among subjects of African and European ancestry. | Brick LA et al. | — | 2019 | → |
| A genetic association study of carotid intima-media thickness (CIMT) and plaque in Mexican Americans and European Americans with rheumatoid arthritis. | Arya R et al. | — | 2018 | → |
| Incorporating Functional Genomic Information to Enhance Polygenic Signal and Identify Variants Involved in Gene-by-Environment Interaction for Young Adult Alcohol Problems. | Salvatore JE et al. | — | 2018 | → |
| Environmental risks outweigh dopaminergic genetic risks for alcohol use and abuse from adolescence through early adulthood. | Coley RL et al. | — | 2017 | → |
| Polygenic Risk, Personality Dimensions, and Adolescent Alcohol Use Problems: A Longitudinal Study. | Li JJ et al. | — | 2017 | → |
| Review: Genetic research on alcohol use outcomes in African American populations: A review of the literature, associated challenges, and implications. | Dick DM et al. | — | 2017 | → |
| The Glycine Receptor-A Functionally Important Primary Brain Target of Ethanol. | Söderpalm B et al. | — | 2017 | → |
| Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses. | Hart AB et al. | — | 2015 | → |
| Genomic influences on alcohol problems in a population-based sample of young adults. | Edwards AC et al. | — | 2015 | → |
| Genetic risk prediction and neurobiological understanding of alcoholism. | Levey DF et al. | — | 2014 | → |
| Genetics of alcoholism. | Iyer-Eimerbrink PA et al. | — | 2014 | → |
| Genotype-environment correlation in the era of DNA. | Plomin R | — | 2014 | → |
| Molecular and neurologic responses to chronic alcohol use. | Costin BN et al. | — | 2014 | → |
| The Genetics, Neurogenetics and Pharmacogenetics of Addiction. | Demers CH et al. | — | 2014 | → |